CLINICAL TRIALS PROFILE FOR ZURANOLONE
✉ Email this page to a colleague
All Clinical Trials for zuranolone
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05655507 ↗ | SAGE-217 Pharmacokinetics (PK) and Safety Study Pediatric Participants With Major Depressive Disorder (MDD) | Not yet recruiting | Sage Therapeutics | Phase 1 | 2023-01-01 | The primary purpose of this study is to evaluate the pharmacokinetics and safety of SAGE-217 in adolescents (ages 12 to 17 years) and children (ages 7 to 11 years) with MDD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for zuranolone
Condition Name
Clinical Trial Progress for zuranolone
Clinical Trial Phase
Clinical Trial Sponsors for zuranolone
Sponsor Name